Table 1. Change in laboratory data after infliximab (IFX) treatment.
| Case 1 | Case 2 | |||||||
|---|---|---|---|---|---|---|---|---|
| Item | Normal range | Before IFX | After IFX | Before IFX |
After IFX | |||
| 1 week | 13 days | 5 days | 11 days | |||||
| CRP | ≤0.3 mg/dL | 3.6 | 1.0 | 2.9 | 5.5 | 1.8 | 0.2 | |
| ESR | <15 mm/hr | 84 | 38 | 23 | 40 | 43 | 27 | |
| Hb | 13.8-17.5 g/dL | 12.2 | 12.3 | 12.5 | 7.9 | 8.6 | 8.8 | |
| WBC | 3900-8800/mm3 | 7700 | 7800 | 4900 | 6000 | 3400 | 3600 | |
| Platelets | 15.2-31.4x104/mm3 | 56.2 | 42.0 | 42.3 | 87.0 | 69.5 | 56.0 | |
| T. protein | 6.7-8.2 g/dL | 7.9 | 7.3 | 6.7 | 7.4 | 6.7 | 6.5 | |
| Albumin | 3.8-5.2 mg/dL | 4.0 | 4.0 | 3.7 | 2.8 | 2.8 | 3.1 | |
| T. cholesterol | 110-220 mg/dL | 147 | 139 | 120 | 124 | 95 | 110 | |
| α2-globulin | 4.8-8.6% | 13.7 | 10.5 | 10.1 | 14.0 | 12.1 | 10.2 | |
| FOB | <200 ng/mL | 153 | n.a. | 211 | 154 | 28 | 820 | |
| CDAI | n.a. | 377 | 183 | 115 | ||||
CDAI = Crohn disease activity index; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; FOB = fecal occult blood; Hb = hemoglobin; IFX = infliximab; n.a. = not available; T. cholesterol = Total cholesterol; T. protein = total protein; WBC = white blood cells.